參考文獻
Abbi S, Guan JL. Focal adhesion kinase: protein interactions and cellular
functions. Histol Histopathol. 2002; 17(4): 1163-1171.
Beurden PS, Von Den Hoff JW. Zymographic techniques for the analysis
of matrix metalloproteinases and their inhibitors. BioTechniques.
2005; 38(1) 73-83.
Björklund M, Koivunen, E. Gelatinase-mediated migration and invasion
of cancer cells. Biochim. Biophys. Acta. 2005; 1755(1) : 37-69.
Bugdayci G, Kaplan T, Sezer S, Turhan T, Koca Y, Kocer B, Yildirim E.
Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of
patients with nonsmall cell lung cancer. Exp Oncol. 2006; 28(2):
169-171.
Chen PN, Hsieh YS, Chiou HL, Chu SC. Silibinin inhibits cell invasion
through inactivation of both PI3K-Akt and MAPK signaling
pathways. Chem Biol Interact. 2005; 156(2): 141-150.
Chen YJ, Chang TC, Liao CT, Wang HM, Yen TC, Chiu CC, Lu YC,
Li HF, Cheng AJ. Head and neck cancer in the betel quid chewing
area: recent advances in molecular carcinogenesis. Cancer Sci. 2008;
99(8): 1507-1514
Chen YJ, Shiao MS, Wang SY. The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs. 2001; 12(2):143-149.
Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A,
Vandebrit C, Cobb MH. MAP kinases. Chem Rev. 2001; 101(8):
2449-2476.
Chien MH, Lin CW, Cheng CW, Wen YC, Yang SF. Matrix
Metalloproteinase (MMP)-2 as a target for head and neck cancer
therapy. Expert Opin Ther Targets. 2013; 17(2): 203-216
Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ Jr, Hiipakka RA,
Liao S, Jones RB. Caffeic acid phenethyl ester suppresses the
proliferation of human prostate cancer cells through inhibition of
p70S6K and Akt signaling networks. Cancer Prev Res. 2012; 5:
(5): 788-797.
Clayman GL, Lippman SM, Laramore GE, Hong WK. Head and neck
cancer. In: Jolland JF, Frei E, Bast RC, Kufe DW, Morton DL,
Weichselbaum RR, eds. Cancer Medicine, 4th edn, chapter 105.
Philadelphia, USA: Williams & Wilkins 1997; 1645-1710.
Condliffe AM, Cadwallader KA, Walker TR, Rintoul RC, Cowburn AS,
Chilvers ER. Phosphoinositide 3-kinase: a critical signaling event in
pulmonary cells. Respir Res. 2000; 1(1): 24-29
Coticchia CM, Curatolo AS, Zurakowski D, Yang J, Daniels KE,
Matulonis UA, Moses MA. Urinary MMP-2 and MMP-9 predict the
presence of ovarian cancer in women with normal CA125 levels.
Gynecol Oncol, 2011; 123(2): 295-300.
Control of oral cancer in developing countries. A WHO meeting. Bull
World Health Organ 1984; 62(6): 817-30.
Coussens LM, Werb Z. Matrix metalloproteinases and the development
of cancer. Chem Bio. 1996; 3(11): 895-904.
Daftary DK, Murti PR, Bhonsle RR, Gupta PC, Mehta FS, Pindborg JJ.
Risk factors and risk markers for oral cancers in high risk areas of the
world. In: Johnson NW, ed. Oral Cancer: Detection of Patients and
Lesions at Risk. Cambridge: Cambridge University Press. 1991; 29-
63.
Davis RJ. Signal transduction by the JNK group of MAP kinase. Cell.
2000; 103(2): 239-252.
Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signaling pathways
in caner. Oncogene. 2007; 26(22): 3279-3290.
Dobrowolski JW, Vohora SB, Sharma K, Shah SA, Naqvi SA, and
Dandiya PC. Antibacterial, antifungal,antiamoebic,
antiinflammatory and antipyretic studies on propolis bee products
J Ethnopharmacol. 1991; 35(1): 77-82.
Egeblad M, Werb Z. New functions for the matrix metalloproteinases in
cancer progression. Nat Rev Cancer. 2002; 2(3): 161-174.
Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol
2007; 35(4): 495-516.
Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal
ulceration and repair. Arch Dermatol Res. 1998; 290: 12-23.
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W,
Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A,
Ensley J, Cooper J. Concurrent chemotherapy and radiotherapy for
organ preservation in advanced laryngeal cancer. N Engl J Med 2003;
349(22): 2091-2098.
Fresno Vara JA, Casado E, de Castrol J, Cejas P, Belda-Iniesta C,
Gonzalez-Baron M. PI3K/Akt signalling pathway and cancer. Cancer
Treat Rev. 2004; 30(2): 193-204
Fromigué O, Hamidouche Z, Marie PJ. Blockade of the RhoA-JNK-c-Jun
-RhoA-JNK-c-Jun -MMP2 cascade by atorvastatin reduces
osteosarcoma cell invasion. J Biol Chem. 2008; 283(45):
30549-30556.
Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation.
Cell. 2011; 144(5): 646-674
He YJ, Liu BH, Xiang DB, Qiao ZY, Fu T, He YH. Inhibitory effect of
caffeic acid phenethyl ester on the growth of SW480 colorectal tumor
cells involves beta-catenin associated signaling pathway down
-regulation. World J Gastroenterol. 2006; 12(31): 4981-4985.
Hong SD, Hong SP, Lee JI, and Lim CY. Expression of matrix
metalloproteinase-2 and -9 in oral squamous cell carcinomas with
regard to the metastatic potential. Oral Oncol 2000; 36(2): 207
-213.
Hsieh YS, Chu SC, Yang SF, Chen PN, Liu YC, Lu KH. Silibinin
suppresses human osteosarcoma MG-63 cell invasion by inhibiting
the ERK-dependent c-Jun/AP-1 induction of MMP-2. Carcinogenesis
2007; 28(5): 977-987.
Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration.
Journal Cell Sci. 2004; 117(20): 4619-4628.
Huang Z, Yan DP, Ge BX. JNK regulates cell migration through
promotion of tyrosine phosphorylation of paxillin. Cell Signal. 2008;
20(11): 2002-2012.
Imren S, Kohn DB, Shimada H, Blavier L, DeClerck YA. Overexpression
of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene
transfer in vivo inhibits tumor growth and invasion. Cancer Res.
1996; 56(13): 2891-2895.
Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways
mediated by ERK, JNK, and p38 protein kinase. Science. 2002; 298
(5600): 1911-1912.
Jung WK, Lee DY, Choi YH, Yea SS, Choi I, Park SG, Seo SK, Lee SW,
Lee CM, Kim SK, Jeon YJ, Choi IW. Caffeic acid phenethyl ester
attenuates allergic airway inflammation and hyperresponsiveness in
murine model of ovalbumin-induced asthma. Life Sci. 2008;
82(13-14): 797-805.
Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S,
Harabuchi Y. Expressions of matrix metalloproteinases in early-stage
oral squamous cell carcinoma as predictive indicators for tumor
metastases and prognosis. Clin Cancer Res. 2004; 10(2): 634-640.
Kerr JF, Wyllie AH, Currie AR. Apoptosis:a basic biological phenomenon
with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;
26(4): 239-257.
Kim D, Kim S, Koh H, Yoon SO, Chung AS, Cho KS, Chung J. Akt/
PKB promotes cancer cell invasion via increased motility and
metalloproteinase production. FASEB J. 2001; 15(11): 1953-1962
Knäuper V, Murphy G. Membrane-type matrix metalloproteinases and
cell surface-associated activation cascades for matrix
metalloproteinases in parks WC, Mecham RP(eds): Matrix
Metalloproteinases. San Diego, CA, Academic press 1998; 199-218.
Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid
chewing, cigarette smoking and alcohol consumption related to oral
cancer in Taiwan. J Oral Pathol Med. 1995; 24(10): 450-453.
Kumar B, Koul S, Petersen J, Khandrika L, Hwa JS, Meacham RB,
Wilson S, Koul HK. p38 Mitogen-activated protein kinase-driven
MAPKAPK2 regulates invasion of bladder cancer by modulation of
MMP-2 and MMP-9 activity. Cancer Res. 2010; 70(2): 832-841.
Kuo HC, Kuo WH, Lee YJ, Lin WL, Chou FP, Tseng TH. Inhibitory
effect of caffeic acid phenethyl ester on the growth of C6 glioma
cells in vitro and in vivo. Cancer Lett. 2006; 234(2):199-208.
Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A,
Takeuchi H, Shirasuna K. Expression of MMPS, MT-MMP, and
TIMPs in squamous cell carcinoma of the oral cavity: correlations
with tumor invasion and metastasis. Head Neck. 1999; 21(7):
627-638.
Kyriakis JM, Avruch J, Mammalian mitogen-activated protein kinase
signal transduction pathways activated by stress and inflammation.
Physiol Rev. 2001; 81(2): 807-869.
Lee Y, Shin DH, Kim JH, Hong S, Choi D, Kim YJ, Kwak MK, Jung Y.
Caffeic acid phenethyl ester-mediated Nrf2 activation and IκB kinase
inhibition are involved in NFκB inhibitory effect: structural analysis
for NFκB inhibition. Eur J Pharmacol. 2010; 643(1): 21-28.
Lee YC, Lin HH, Hsu CH, Wang CJ, Chiang TA, Chen JH. Inhibitory
effects of andrographolide on migration and invasion in human
non-small cell lung cancer A549 cells via down-regulation of PI3K /
Akt signaling pathway. Eur J Pharmacol. 2010; 632(1-3): 23-32.
Lee YT, Don MJ, Hung PS, Shen YC, Lo YS, Chang KW, Chen CF,Ho
LK. Cytotoxicity of phenolic acid phenethyl esters on oral cancer
cells. Cancer Lett. 2005; 223(1): 19-25.
Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB,
Bar-Sagi D, Davis RJ. The Bax subfamily if Bcl2-related proteins is
essential for apoptotic signal transduction by c-Jun NH(2)-terminal
kinase. Mol Cell Biol. 2002; 22(13): 4929-4942.
Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH,Chen
IH, Huang SF, Cheng AJ, Yen TC. Analysis of risk factors predictive
of local tumor control in oral cavity cancer. Ann Surg Oncol. 2008;
15(3): 915-922.
Liao CT, Kang CJ, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin
CH, Cheng AJ, Chen IH, Huang SF, Yen TC. Survival of second and
multiple primary tumors in patients with oral cavity squamous cell
carcinoma in the betel quid chewing area. Oral Oncol 2007; 43(8):
811-819.
Lo WL, Kao SY, Chi LY, Wong YK, Chang RC. Outcomes of oral
squamous cell carcinoma in Taiwan after surgical therapy: factors
affecting survival. J Oral Maxillofac Surg 2003; 61(7): 751-758.
Mackay AR, Corbitt RH, Hartzler JL, Thorgeirsson UP. Basement
membrane type IV collagen degradation: evidence for the
involvement of a proteolytic cascade independent of
metalloproteinases. Cancer Res. 1990; 50(18): 5997-6001.
Mercer KE, Pritchard CA. Raf proteins and cancer: B-Raf is identified as
a mutational target. Biocheim Biophys Acta. 2003; 1653(1): 25-40.
Mevorach D. The immune response to apoptotic cells. Ann NY Acas Sci
1999; 887: 191-198
Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS,
Koboldt C, Mestre JR, Grunberger D, Sacks PG, Tanabe T,
Dannenberg AJ. Inhibitory effects of caffeic acid phenethyl ester on
the activity and expression of cyclooxygenase-2 in human oral
epithelial cells and in a rat model of inflammation. Cancer Res.
1999; 59(10): 2347-2352.
Mirzoeva OK, Yaqoob P, Knox KA, Calder PC. Inhibition of ICE- family
cysteine proteases rescues murine lymphocytes from lipoxygenase
inhibitor-induced apoptosis. FEBS Lett.1996; 396(2-3): 266-270.
Nagata S. Apoptotic DNA fragmentation. Exp Cell Res. 2000;
256(1): 12-18.
Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix
metalloproteinases: biologic activity and clinical implications. J Clin
Oncol. 2000; 18(5): 1135-1149.
Nuttall RK, Pennington CJ, Taplin J, Wheal A, Yong VW, Forsyth PA,
Edwards DR. Elevated membrane-type matrix metalloproteinases in
gliomas revealed by profiling proteases and inhibitors in human
cancer cells. Mol Cancer Res. 2003; 1(5): 333-345.
Pan MR, Hung WC. Nonsteroidal anti-inflammatory drugs inhibit matrix
Metalloproteinase-2 via suppression of the ERK / Sp1-mediated
transcription. J Biol Chem. 2002; 277(36): 32775-32780.
Park BK, Zeng X, Glazer RI. Akt1 induces extracellular matrix invasion
and matrix metalloproteinase-2 activity in mouse mammary epithelial
cells. Cancer Res. 2001; 61(20): 7647-7653.
Palona I, Namba H, Mitsutake N, Starenki D, Podtcheko A, Sedliarou I,
Ohtsuru A, Saenko V, Nagayama Y, Umezawa K, Yamashita S.
BRAFV600E promotes invasiveness of thyroid cancer cells through
nuclear factor kappaB activation. Endocrinology. 2006; 147(12):
5699-5707.
Qin H, Sun Y, Benveniste EN. The transcription factors Sp1, Sp3, and
AP-2 are required for constitutive matrix metalloproteinase-2 gene
expression in astroglioma cells. J Biol Chem. 1999; 274(41):
29130-29137.
Ranuncolo SM, Armanasco E, Cresta C, De Kier Joffe EB, Puricelli L.
Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up
and in the assessment of prognosis in breast cancer patients. Int J
Cancer. 2003; 106(5); 745-751.
Sauer CG, Kappeler A, Späth M, Kaden JJ, Michel MS, Mayer D,Bleyl
U, Grobholz R. Expression and activity of matrix metalloproteinases
-2 and -9 in serum, core needle biopsies and tissue specimens of
prostate cancer patients. Virchows Arch. 2004; 444(6): 518-526.
Shen LC, Chen YK, Lin LM, Shaw SY. Anti-invasion and anti-tumor growth effect of doxyzcycline treatment for human oral squamous-cell carcinoma – in vitro and in vivo studies. Oral Oncol.
2010; 46(3): 178-184
Song N, Sung H, Choi JY, Han S, Jeon S, Song M, Lee Y, Park C, Park
SK, Lee KM, Yoo KY, Noh DY, Ahn SH, Lee SA, Kang D.
Preoperative serum levels of matrix metalloproteinase-2 (MMP-2)
and survival of breast cancer among Korean women. Cancer
Epidemiol Biomarkers Prev. 2012; 21(8): 1371-1380.
Stetler-Stevenson WG, Liotta LA, Kleiner DE. Extracellular matrix 6:
role of matrix metalloproteinases in tumor invasion and metastasis.
FASEB J. 1993; 7(15): 1434-1441.
Steller H. Mechanisms and genes of cellular suicide. Science. 1995; 267:
(5203): 1445-1449.
Valente P, Fassina G, Melchiori A, Masiello L, Cilli M, Vacca A, Onisto
M, Santi L, Stetler-Stevenson WG, Albini A. TIMP-2 overexpression
reduces invasion and angiogenesis and protects B16F10 melanoma
cells from apoptosis. Int J Cancer. 1998; 75(2): 246 -253.
Visscher DW, Höyhtyä M, Ottosen SK, Liang CM, Sarkar FH, Crissman
JD, Fridman R. Enhanced expression of tissue inhibitor of
metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas
correlates with tumor recurrence. Int J Cancer. Cancer.1994;
59(3): 339-344.
Watabe M, Hishikawa K, Takayanagi A, Shimizu N, Nakaki T. Caffeic
acid phenethyl ester induces apoptosis by inhibition of NFkappaB
and activation of Fas in human breast cancer MCF-7 cells. J Biol
Chem. 2004; 279(7): 6017-6026.
Weng CJ, Chau CF, Hsieh YS, Yang SF, Yen GC. Lucidenic acid inhibits
PMA-induced invasion of human hepatoma cells through
inactivating MAPK/ERK signal transduction pathway and reducing
binding activities of NF-κB and AP-1. Carcinogenesis. 2008; 29(1):
147-156.
Wenston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin
Genet Dev. 2002; 12(1): 14-21
Westermarck J, Kahari VM. Regulation of matrix metalloproteinase
expression in tumor invasion. FASEB J. 1999; 13(8): 781-792.
Wong TS, Kwong DLW, Sham JST, Wei WI, Kwong YL, Yuen APW.
Clinicopathologic significance of plasma matrix metalloproteinase
-2 and -9 levels in patients with undifferentiated nasopharyngeal
Carcinoma. Eur J Surg Oncol. 2004; 30(5): 560-564.
Yang SF, Yang WE, Kuo WH, Chang HR, Chu SC, Hsieh YS.
Antimetastatic potentials of flavones on oral cancer cell via an
inhibition of matrix-degrading proteases. Arch Oral Biol. 2008; 53(3):
287-294.
Yokoyama M, Ochi K, Ichimura M, Mizushima T, Shinji T, Koide N,
Tsurumi T, Hasuoka H, Harada M. Matrix metalloproteinase- 2 in
pancreatic juice for diagnosis of pancreatic cancer. Pancreas. 2002
; 24(4): 344-347.
Yoon SO, Park SJ, Yun CH, Chung AS. Roles of matrix
metalloproteinases in tumor metastasis and angiogenesis. J Biochem
Mol Biol. 2003;36(1): 128-137.
Zhong J, Gencay MM, Bubendorf L, Burgess JK, Parson H, Robinson
BW, Tamm M, Black JL, Roth M. ERK1/2 and p38 MAP kinase
control MMP-2, MT1-MMP, and TIMP action and affect cell
migration: a comparison between mesothelioma and mesothelial cells.
J Cell Physiol. 2006; 207(2): 540-552.
譚健民 粒線體與細胞凋亡 生物醫學 2009; 2(3): 250-268